Nalagenetics
Swati Tomar, Ph.D., serves as an Advisor in Clinical Genomics and Variant Interpretation at NalaGenetics since June 2025, focusing on standardizing and interpreting genomic data to enhance clinical accuracy and research impact. Prior experience includes three years as a Global Product Manager at SOPHiA GENETICS, where strategic management of SaaS-based healthcare products led to a significant revenue increase. Swati worked at the National University of Singapore as a Senior Research Fellow and Clinical NGS Platform Manager, leading the interpretation of NGS data for rare pediatric diseases and optimizing diagnostic workflows. Additional roles include Senior Research Fellow at the Genome Institute of Singapore and various positions in research and education during earlier academic pursuits, including a Ph.D. in Biomedical Science from the University of South Carolina and a Bachelor of Technology in Biotechnology from Guru Gobind Singh Indraprastha University.
This person is not in any teams
This person is not in any offices
Nalagenetics
Nalagenetics was built with the passion to give access to personalized prescription to as many people as possible. Two of the co-founders have seen and felt firsthand the betrayal of drugs that were supposed to cure their family members, but instead caused them permanent side effects. It was then that they realized, without understanding how to best use them, innovations in pharma and biotech, meant little to the people who need it most.